Literature DB >> 10666059

Mechanism of preserved positive lusitropy by cAMP-dependent drugs in heart failure.

T Tanigawa1, M Yano, M Kohno, T Yamamoto, T Hisaoka, K Ono, T Ueyama, S Kobayashi, Y Hisamatsu, T Ohkusa, M Matsuzaki.   

Abstract

In tachycardia-induced heart failure (HF), positive lusitropic effects of milrinone or dobutamine were assessed by evaluating the time constant of left ventricular (LV) pressure decay (tau) and Ca(2+)-ATPase activity of the sarcoplasmic reticulum (SR). The peak value of the positive first derivative of LV pressure (+dP/dt) was less increased, either by dobutamine (2-10 microg x kg(-1) x min(-1)) or by milrinone (4-20 microg/kg), in HF than in control (P < 0.05), whereas tau was shortened to an extent similar to that in control with dobutamine [P = not significant (NS)] and to an even greater extent with milrinone (P < 0.05). Ca(2+)-ATPase activity increased similarly in HF and control with dobutamine (1 microM; +11% in HF vs. +12% in control, P = NS), whereas it increased more with milrinone (1 microM; +19% in HF vs. +11% in control, P < 0.05). Ca(2+)-ATPase activity-cAMP relationships were shifted to the left by milrinone or dobutamine in HF compared with control. Thus, in HF, the sensitivity of Ca(2+)-ATPase activity to cAMP was increased on addition of cAMP-dependent inotropic agents, contributing to the preservation of positive lusitropy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666059     DOI: 10.1152/ajpheart.2000.278.2.H313

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  4 in total

1.  Vascular Dilation, Tachycardia, and Increased Inotropy Occur Sequentially with Increasing Epinephrine Dose Rate, Plasma and Myocardial Concentrations, and cAMP.

Authors:  Mikhail Y Maslov; Abraham E Wei; Matthew J Pezone; Elazer R Edelman; Mark A Lovich
Journal:  Heart Lung Circ       Date:  2015-02-23       Impact factor: 2.975

2.  [Continuous beta-block with esmolol in combination with enoximone: influence on cardiac function in high risk patients undergoing vascular surgery].

Authors:  S Suttner; J Boldt; K Lang; J Mayer; K Röhm; S N Piper
Journal:  Anaesthesist       Date:  2008-03       Impact factor: 1.041

3.  High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect: an example with epicardial inotropic drug delivery.

Authors:  Mikhail Y Maslov; Elazer R Edelman; Abraham E Wei; Matthew J Pezone; Mark A Lovich
Journal:  J Control Release       Date:  2013-07-18       Impact factor: 9.776

4.  Ischemia reperfusion dysfunction changes model-estimated kinetics of myofilament interaction due to inotropic drugs in isolated hearts.

Authors:  Samhita S Rhodes; Amadou K S Camara; Kristina M Ropella; Said H Audi; Matthias L Riess; Paul S Pagel; David F Stowe
Journal:  Biomed Eng Online       Date:  2006-03-02       Impact factor: 2.819

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.